Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Laffitte

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Dermatology (Basel, Switzerland)|December 1, 2006
Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohortDagmar Simon, Jann Lübbe, Brunello Wüthrich, et al.
Dermatology (Basel, Switzerland)|June 21, 2016
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis VulgarisAntonios G A Kolios, Nikhil Yawalkar, Mark Anliker, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Dermatology (Basel, Switzerland)|January 6, 2021
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment PathwayJulia-Tatjana Maul, Florian Anzengruber, Curdin Conrad, et al.
The American Journal of Tropical Medicine and Hygiene|January 27, 2007
Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution?Gloria Morizot, Pascal Delgiudice, Eric Caumes, et al.
Dermatology (Basel, Switzerland)|January 20, 2017
Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis RegistryPierre Jungo, Julia-Tatjana Maul, Vahid Djamei, et al.
Dermatology (Basel, Switzerland)|January 12, 2017
Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTTJulia-Tatjana Maul, Vahid Djamei, Antonios G A Kolios, et al.
JAMA Dermatology|March 30, 2022
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With PsoriasisAstrid M van Huizen, Stef P Menting, Rolland Gyulai, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Dermatology (Basel, Switzerland)|December 1, 2006
Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohortDagmar Simon, Jann Lübbe, Brunello Wüthrich, et al.
Dermatology (Basel, Switzerland)|June 21, 2016
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis VulgarisAntonios G A Kolios, Nikhil Yawalkar, Mark Anliker, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Dermatology (Basel, Switzerland)|January 6, 2021
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment PathwayJulia-Tatjana Maul, Florian Anzengruber, Curdin Conrad, et al.
The American Journal of Tropical Medicine and Hygiene|January 27, 2007
Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution?Gloria Morizot, Pascal Delgiudice, Eric Caumes, et al.
Dermatology (Basel, Switzerland)|January 20, 2017
Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis RegistryPierre Jungo, Julia-Tatjana Maul, Vahid Djamei, et al.
Dermatology (Basel, Switzerland)|January 12, 2017
Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTTJulia-Tatjana Maul, Vahid Djamei, Antonios G A Kolios, et al.
JAMA Dermatology|March 30, 2022
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With PsoriasisAstrid M van Huizen, Stef P Menting, Rolland Gyulai, et al.
Pageof 8